These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16738034)
1. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Man SF; Connett JE; Anthonisen NR; Wise RA; Tashkin DP; Sin DD Thorax; 2006 Oct; 61(10):849-53. PubMed ID: 16738034 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083 [TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein in patients with COPD, control smokers and non-smokers. Pinto-Plata VM; Müllerova H; Toso JF; Feudjo-Tepie M; Soriano JB; Vessey RS; Celli BR Thorax; 2006 Jan; 61(1):23-8. PubMed ID: 16143583 [TBL] [Abstract][Full Text] [Related]
5. [C-reactive protein level and the correlation between lung function and CRP levels in patients with chronic obstructive pulmonary diseases]. Wu SJ; Chen P; Jiang XN; Liu ZJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):444-6. PubMed ID: 16190395 [TBL] [Abstract][Full Text] [Related]
6. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease. Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell distribution and survival in patients with chronic obstructive pulmonary disease. Seyhan EC; Özgül MA; Tutar N; Ömür I; Uysal A; Altin S COPD; 2013 Aug; 10(4):416-24. PubMed ID: 23537076 [TBL] [Abstract][Full Text] [Related]
9. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Sin DD; Man SF Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253 [TBL] [Abstract][Full Text] [Related]
10. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H; Luo H; Chen P; Li Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [TBL] [Abstract][Full Text] [Related]
11. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study. Zhang J; Rutten FH; Cramer MJ; Lammers JW; Zuithoff NP; Hoes AW Fam Pract; 2011 Oct; 28(5):474-81. PubMed ID: 21602286 [TBL] [Abstract][Full Text] [Related]
12. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD. Fawzy A; Anderson JA; Cowans NJ; Crim C; Wise R; Yates JC; Hansel NN Respir Res; 2019 May; 20(1):86. PubMed ID: 31068182 [TBL] [Abstract][Full Text] [Related]
13. The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD). Park HY; Man SF; Tashkin D; Wise RA; Connett JE; Anthonisen NA; Sin DD PLoS One; 2013; 8(4):e61315. PubMed ID: 23637811 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and other predictors of poor outcome in patients hospitalized with exacerbations of chronic obstructive pulmonary disease. Ruiz-González A; Lacasta D; Ibarz M; Martínez-Alonso M; Falguera M; Porcel JM Respirology; 2008 Nov; 13(7):1028-33. PubMed ID: 18945322 [TBL] [Abstract][Full Text] [Related]
15. Genetic and biochemical markers of obstructive lung disease in the general population. Dahl M Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054 [TBL] [Abstract][Full Text] [Related]
17. Acute Phase Proteins as Predictors of Survival in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation. Sneh A; Pawan T; Randeep G; Anant M; Mani K; Hadda V; Madan K COPD; 2020 Feb; 17(1):22-28. PubMed ID: 31820666 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels and survival in patients with moderate to very severe COPD. de Torres JP; Pinto-Plata V; Casanova C; Mullerova H; Córdoba-Lanús E; de Fuentes MM; Aguirre-Jaime A; Celli BR Chest; 2008 Jun; 133(6):1336-1343. PubMed ID: 18339787 [TBL] [Abstract][Full Text] [Related]
19. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. Parrinello CM; Lutsey PL; Ballantyne CM; Folsom AR; Pankow JS; Selvin E Am Heart J; 2015 Aug; 170(2):380-9. PubMed ID: 26299237 [TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]